UA57367A - Способ лечения тяжелой формы эпидемического паротита у взрослых - Google Patents
Способ лечения тяжелой формы эпидемического паротита у взрослых Download PDFInfo
- Publication number
- UA57367A UA57367A UA2002097288A UA200297288A UA57367A UA 57367 A UA57367 A UA 57367A UA 2002097288 A UA2002097288 A UA 2002097288A UA 200297288 A UA200297288 A UA 200297288A UA 57367 A UA57367 A UA 57367A
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- patients
- days
- adults
- patient
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 208000005647 Mumps Diseases 0.000 title claims abstract description 7
- 208000010805 mumps infectious disease Diseases 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 238000012876 topography Methods 0.000 claims 1
- 230000001900 immune effect Effects 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010025482 malaise Diseases 0.000 description 8
- 238000001784 detoxification Methods 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 210000003079 salivary gland Anatomy 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 206010025327 Lymphopenia Diseases 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- ILSOAHPXYZRFBA-UHFFFAOYSA-N n-benzyl-1-methylpyridin-1-ium-4-carboxamide;iodide Chemical compound [I-].C1=C[N+](C)=CC=C1C(=O)NCC1=CC=CC=C1 ILSOAHPXYZRFBA-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 238000010606 normalization Methods 0.000 description 4
- 230000036642 wellbeing Effects 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010033645 Pancreatitis Diseases 0.000 description 3
- 230000002519 immonomodulatory effect Effects 0.000 description 3
- 230000004957 immunoregulator effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 201000005737 orchitis Diseases 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 241001327638 Cimex lectularius Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100001039 immunological change Toxicity 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ лечения тяжелой формы эпидемического паротита у взрослых включает в себя применение детоксицирующих препаратов и амизона. Кроме того, больным назначают препарат растительного происхождения протефлазид внутрь по 8-10 капель три раза в день на протяжении 12-14 дней подряд.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002097288A UA57367A (ru) | 2002-09-09 | 2002-09-09 | Способ лечения тяжелой формы эпидемического паротита у взрослых |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002097288A UA57367A (ru) | 2002-09-09 | 2002-09-09 | Способ лечения тяжелой формы эпидемического паротита у взрослых |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA57367A true UA57367A (ru) | 2003-06-16 |
Family
ID=74285867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002097288A UA57367A (ru) | 2002-09-09 | 2002-09-09 | Способ лечения тяжелой формы эпидемического паротита у взрослых |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA57367A (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3381G2 (ru) * | 2006-06-19 | 2008-03-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Метод лечения хронического паротита у детей |
-
2002
- 2002-09-09 UA UA2002097288A patent/UA57367A/ru unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3381G2 (ru) * | 2006-06-19 | 2008-03-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Метод лечения хронического паротита у детей |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Becker et al. | Management and prevention of tetanus | |
| KR102705552B1 (ko) | 만성 치은염의 치료 또는 경감을 위한 조성물 | |
| Harris | CDC assesses risk from BA. 2.86, highly mutated COVID-19 variant | |
| Harris | FDA approves maternal RSV vaccine | |
| Harris | Artemisinin resistance increasing | |
| Pulte | Homoeopathic Domestic Physician | |
| UA57367A (ru) | Способ лечения тяжелой формы эпидемического паротита у взрослых | |
| Harris | Binge drinking, other substance use up in midlife adults | |
| Harris | Most fish oil supplements make unsupported claims | |
| Harris | One in 5 males worldwide has high-risk genital HPV | |
| Harris | Deep Brain Stimulation May Improve Function Years After Stroke | |
| Harris | Severe COVID-19 Linked to Enduring Immune System Changes | |
| Scott | The DMSO Handbook for Doctors | |
| Pierce et al. | Variations in the Reducing Power (Sugar) of Normal Human Blood | |
| UA71335A (ru) | Способ лечения взрослых больных с тяжелым течением эпидемического паротита | |
| IvakhivA et al. | Clinical cases of atypical and severe botulism | |
| BLY | Lues maligna: with report of two cases | |
| Fever | to dissolve spontaneously. | |
| Croftan | New Clinical Therapeutics: A Handbook on the Special Treatment of Internal Disease | |
| Pauling | Compound-65 | |
| Campbell et al. | INDIRECT TREATMENT OF A PRESUMABLY SYPHILITIC CHILD BY MATERNAL THERAPY DURING LACTATION: REPORT OF CASE | |
| BOYERS | PRESENTATION OF CASE OF INFECTION WITH COUNCILMANIA DISSIMILIS KOFOID | |
| UA57369A (ru) | Способ лечения тяжелой формы кори у взрослых | |
| Andrews | The Medical Summary: A Monthly Journal of Practical Medicine, New Preparations | |
| BETCHER | Editorial Views: Let's Set Our Sights |